FOXO1 and Hyperglycemia: It has been reported that liver-specific deletion of Sirt1 upregulates the expression of G6Pase and PCK1 by impairing the mTorc2/AKT/FOXO1 pathway and thus increases hepatic glucose production and chronic hyperglycaemia [14].